FDA approves Amgen's heart-failure drug Corlanor

April 16, 2015 3:58 PM

1 0

FDA approves Amgen's heart-failure drug Corlanor

The U.S. Food and Drug Administration on Wednesday approved Amgen Inc.’s heart-failure treatment Corlanor, which had been designated for priority review in August.

The drug is an oral medication intended to regulate heart rate and reduce the risk of hospitalization for worsening heart failure in patients with stable, chronic heart failure caused by a poorly-contracting lower-left part of the heart.

Read more

To category page

Loading...